C. DeBoer
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Microbiology top 10%
Papers in
-
- Glutathione Transferases and Polymorphisms 1
- Genomics and Phylogenetic Studies 1
- Cancer therapeutics and mechanisms 1
-
- Microbial Natural Products and Biosynthesis 3
- Co-authors
- D. H. Peterson (1 shared paper)Richard J. Wnuk (1 shared paper)P. A. MEULMAN (1 shared paper)Jill O’Donnell-Tormey (2 shared papers)C F Nathan (2 shared papers)Karl W. Lanks (1 shared paper)A Dietz (3 shared papers)E. Louis Caron (1 shared paper)
- Journals
- The Journal of Antibiotics (3 papers)The Journal of Experimental Medicine (1 paper)Journal of the American Chemical Society (1 paper)Journal of Clinical Investigation (1 paper)PubMed (3 papers)
- Partner nations
- United States
In The Last Decade
C. DeBoer
9 papers receiving 798 citations
C. DeBoer's Hit Papers
Peers
Comparison fields: 5 of 94
- Toxicology 55
- Microbiology 9
- Pharmacology 168
- Molecular Biology 537
- Biotechnology 45
Countries citing papers authored by C. DeBoer
This map shows the geographic impact of C. DeBoer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. DeBoer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. DeBoer more than expected).
Fields of papers citing papers by C. DeBoer
This network shows the impact of papers produced by C. DeBoer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. DeBoer. The network helps show where C. DeBoer may publish in the future.
Co-authors
The 11 scholars most cited alongside C. DeBoer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | GELDANAMYCIN, A NEW ANTIBIOTIC Hit paper breakdown → | 1970 | 365 |
| 2 | 1987 | 241 | |
| 3 | Streptozotocin, a new antibacterial antibiotic. | 1998 | 66 |
| 4 | 1985 | 58 | |
| 5 | 1976 | 35 | |
| 6 | 1953 | 33 | |
| 7 | Streptolydigin, a new antimicrobial antibiotic. I. Biologic studies of streptolydigin. | 2002 | 18 |
| 8 | 1980 | 17 | |
| 9 | Fervenulin, a new crystalline antibiotic. I. Discovery and biological activities. | 1998 | 1 |
About C. DeBoer
C. DeBoer is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Molecular Medicine and Surgery, having authored 9 papers that have together received 834 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (3 papers), Antibiotic Resistance in Bacteria (2 papers), Carcinogens and Genotoxicity Assessment (1 paper), Antimicrobial Peptides and Activities (1 paper), Glutathione Transferases and Polymorphisms (1 paper), Genomics and Phylogenetic Studies (1 paper), Blood disorders and treatments (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Toxicology (55 citations), Microbiology (9 citations), Pharmacology (168 citations), Molecular Biology (537 citations) and Biotechnology (45 citations). C. DeBoer has collaborated with scholars based in United States. Frequent co-authors include D. H. Peterson, Richard J. Wnuk, P. A. MEULMAN, Jill O’Donnell-Tormey, C F Nathan, Karl W. Lanks, A Dietz, E. Louis Caron, J. W. Hinman and Lester A. Dolak. Their work appears in journals such as The Journal of Antibiotics, The Journal of Experimental Medicine, Journal of the American Chemical Society, Journal of Clinical Investigation and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.